Teladoc Health Inc buy Royal Bank of Canada
Start price
21.02.24
/
50%
€14.32
Target price
21.02.25
€23.12
Performance (%)
-54.24%
Price
09.08.24
€6.55
Summary
This prediction is currently active. Massive losses of -54.24% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 21.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | -9.986% | -9.986% |
iShares Core DAX® | 0.393% | -2.618% |
iShares Nasdaq 100 | 0.394% | -10.309% |
iShares Nikkei 225® | 1.038% | -8.365% |
iShares S&P 500 | -0.046% | -4.991% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $30.00 to $25.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.29
26.04.24
26.04.24
€16.82
26.04.25
26.04.25
-46.68%
09.08.24
09.08.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-60.19%
09.08.24
09.08.24